BOP ; Homo sapiens






106 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1378092 Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther 1992 Jul 1
2 1428528 New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156. Int J Pept Protein Res 1992 Apr 1
3 1428539 Effect of copper(II) chloride on suppression of racemization in peptide synthesis by the mixed anhydride and related methods. Int J Pept Protein Res 1992 Jul 1
4 1486219 Mechanism of prevention of development of N-nitrosobis(2-oxopropyl)amine induced pancreatic carcinoma by a protein-free diet in hamsters. Oncol Res 1992 1
5 1539363 [Commercially available substitutes for transplants of human bone]. Ugeskr Laeger 1992 Feb 3 1
6 1712307 Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor. Eur J Pharmacol 1991 Jan 25 1
7 1830308 Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. J Biol Chem 1991 Jul 25 8
8 1830459 Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors. Am J Physiol 1991 Jul 2
9 1833525 Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells. J Pharmacol Exp Ther 1991 Oct 2
10 1894448 Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8. Int J Pept Protein Res 1991 Apr 1
11 2137820 Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes. J Biol Chem 1990 Mar 15 17
12 2141663 Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells. Life Sci 1990 2
13 2279850 Solid-phase synthesis of peptides containing phosphoserine using phosphate tert.-butyl protecting group. Int J Pept Protein Res 1990 Sep 1
14 2323890 BOP reagent for the coupling of pGlu and Boc-His(Tos) in solid phase peptide synthesis. Int J Pept Protein Res 1990 Feb 7
15 2467806 Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol 1989 Feb 1
16 2530338 Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther 1989 Nov 1
17 2534431 Binding of an [125I] labelled thromboxane A2/prostaglandin H2 receptor agonist to baboon platelets. Prostaglandins 1989 Dec 2
18 2711904 Discectomies of the lower cervical spine using interbody biopolymer (B.O.P.) implants. Advantages in the treatment of complicated cervical arthrosis. A review of 150 cases. Acta Neurochir (Wien) 1989 1
19 2896637 Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2. Int J Pept Protein Res 1988 Jan 3
20 3082822 A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction. Jpn J Cancer Res 1986 Feb 1
21 3952782 [A differential description of the SDAT (senile dementia Alzheimer type) patient using 2 behavior observation scales: the BOP (Older Patients Rating Scale) and the GOS-G (Behavior Observation Scale-Geriatrics)]. Tijdschr Gerontol Geriatr 1986 Feb 1
22 3960034 Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mutat Res 1986 May 1
23 7693604 Cyclic peptide substrates of pp60c-src. Synthesis and evaluation. Int J Pept Protein Res 1993 Sep 1
24 7697798 Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis by N-nitrosobis(2-oxopropyl)amine in hamsters. Carcinogenesis 1995 Mar 2
25 7741764 Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochem Pharmacol 1995 Mar 30 3
26 7758179 Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 1995 Jun 1 1
27 7932171 Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther 1994 Sep 2
28 8071836 Characterization of human peripheral blood monocyte thromboxane A2 receptors. J Pharmacol Exp Ther 1994 Aug 3
29 8101004 Selective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt coupling. Proc Natl Acad Sci U S A 1993 Jul 1 6
30 8279549 Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol 1993 Dec 2
31 8353856 Metabolism and activation of pancreas specific nitrosamines by pancreatic ductal cells in culture. Carcinogenesis 1993 Aug 1
32 8570669 Search for new anticonvulsant compounds. Part 1: Synthesis, physicochemical and anticonvulsant properties of new derivatives of alpha-amino-gamma-phthalimidobutyric acid. Pharmazie 1995 Nov 3
33 8627525 Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q. J Pharmacol Exp Ther 1996 May 2
34 8635152 Lack of inhibitory effects of beta-carotene, vitamin C, vitamin E and selenium on development of ductular adenocarcinomas in exocrine pancreas of hamsters. Cancer Lett 1996 Jun 5 2
35 8769820 Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase. Am J Physiol 1996 Jan 2
36 8837733 Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Arch Biochem Biophys 1996 Oct 1 1
37 9022983 Use of BOP-Cl in the presence of Boc-amino monothioacids for the thioacylation of imino acid residues. Bioorg Med Chem 1996 Dec 3
38 9119950 [The significance of blood group-related antigen A in a pancreatic cell line (PGHAM-1) in hamsters. With special reference to cell proliferation]. Nihon Ika Daigaku Zasshi 1997 Feb 1
39 9230485 Total synthesis of zervamicin IIB and its deuterium-labelled analogues. J Pept Sci 1997 May-Jun 2
40 9520085 Localization of galectin-3 in normal and diseased pancreatic tissue. Int J Pancreatol 1998 Feb 2
41 9808535 Establishment of tumor cell culture (ILA) derived from hamster pancreatic islets treated with BOP. Int J Cancer 1998 Nov 23 1
42 9915793 Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem 1999 Jan 29 1
43 10402213 Thromboxane receptors in human kidney tissues. Prostaglandins Other Lipid Mediat 1999 Jun 1
44 10438543 Tyrosine phosphorylation of cortactin associated with Syk accompanies thromboxane analogue-induced platelet shape change. J Biol Chem 1999 Aug 13 1
45 10503910 Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters. Cancer Lett 1999 Sep 1 1
46 10602330 Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol 1999 Dec 1
47 10693655 TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activity. Antivir Chem Chemother 2000 Jan 1
48 10990626 Bounded analytic bond-order potentials for sigma and pi bonds Phys Rev Lett 2000 May 1 2
49 11149848 A tetramethyl rhodamine (Tamra) phosphoramidite facilitates solid-phase-supported synthesis of 5'-Tamra DNA. J Org Chem 2000 Dec 29 4
50 11504827 Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases. J Pharmacol Exp Ther 2001 Sep 2